Expressions of Hmam Mrna and CD44V6 Mrna in Breast Cancer

LIU Jianlun,YANG Huawei,CAO Ji,YANG Nanwu

DOI: https://doi.org/10.3781/j.issn.1000-7431.2005.06.017

2005-01-01

Tumori

Abstract:Objective To study the expression and clinical significance of human mammoglobin (hMAM) mRNA and CD44V6 mRNA, and to evaluate the possibility of hMAM mRNA and CD44V6 mRNA as a tumor marker of micrometastasis in breast cancer. Methods Expressions of hMAM mRNA and CD44V6 mRNA were detected in samples of breast cancer and adjacent non-tumoral tissues, benign breast tumor and in peripheral blood from patients with breast cancer and breast benign lesions, and healthy volunteers by nested reverse transcription polymerase chain reaction (nested-RT-PCR), and other cancers (including gastric carcinomas,colorectal carcinomas, esophageal carcinomas, lung carcinomas, and ovary carcinomas) were analyzed for hMAM-mRNA expression by nested-RT-PCR method. Results The positive rates of hMAM mRNA were 96. 72%, 96. 72% and 93. 75% in breast cancer, corresponding normal tissues and breast benign tumor, there was no significant difference from them (P0. 05). hMAM mRNA was not expressed in other cancers. The expression of CD44V6 mRNA was significantly higher than that of adjacent non-tumoral tissues and benign breast tumor. The positive expression rate of hMAM mRNA was 45. 90% in peripheral blood from patients with breast cancer, and the positive rate of hMAM mRNA in peripheral blood of breast cancer patients with stage Ⅳ was significantly higher than those patients with stage Ⅰ ,Ⅱ and Ⅲ (P 0. 05). No hMAM mRNA expression was found in peripheral blood of patients with breast benign lesions or healthy volunteers. The positive expression of CD44V6 mRNA was 83. 61%, 81. 25% and 80. 00% in peripheral blood of patients with breast cancer, breast benign lesions, and healthy volunteers, respectively. No significant difference was found among three groups(P 0. 05). Conclusion hMAM mRNA is specific expression in breast tissue, and the positive expression of hMAM mRNA in peripheral blood might predict hematogenous metastatic spreading of tumor cells, and hMAM mRNA may be potential biological marker for detecting breast cancer micrometastasis. CD44V6 mRNA as a marker of mammary carcinoma cells in peripheral blood is lack of specificity.